237 related articles for article (PubMed ID: 2450068)
1. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.
Tsuzuki K; Yokosawa N; Syuto B; Ohishi I; Fujii N; Kimura K; Oguma K
Infect Immun; 1988 Apr; 56(4):898-902. PubMed ID: 2450068
[TBL] [Abstract][Full Text] [Related]
2. Sequence homology between tetanus and botulinum toxins detected by an antipeptide antibody.
Halpern JL; Smith LA; Seamon KB; Groover KA; Habig WH
Infect Immun; 1989 Jan; 57(1):18-22. PubMed ID: 2909486
[TBL] [Abstract][Full Text] [Related]
3. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.
Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G
Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459
[TBL] [Abstract][Full Text] [Related]
4. Cloning and whole nucleotide sequence of the gene for the light chain component of botulinum type E toxin from Clostridium butyricum strain BL6340 and Clostridium botulinum type E strain Mashike.
Fujii N; Kimura K; Yashiki T; Tsuzuki K; Moriishi K; Yokosawa N; Syuto B; Oguma K
Microbiol Immunol; 1992; 36(3):213-20. PubMed ID: 1602997
[TBL] [Abstract][Full Text] [Related]
5. Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies.
Kubota T; Watanabe T; Yokosawa N; Tsuzuki K; Indoh T; Moriishi K; Sanda K; Maki Y; Inoue K; Fujii N
Appl Environ Microbiol; 1997 Apr; 63(4):1214-8. PubMed ID: 9097417
[TBL] [Abstract][Full Text] [Related]
6. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.
Oguma K; Agui T; Syuto B; Kimura K; Iida H; Kubo S
Infect Immun; 1982 Oct; 38(1):14-20. PubMed ID: 6183207
[TBL] [Abstract][Full Text] [Related]
7. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
Oguma K; Syuto B; Iida H; Kubo S
Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies.
Oguma K; Murayama S; Syuto B; Iida H; Kubo S
Infect Immun; 1984 Feb; 43(2):584-8. PubMed ID: 6198281
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.
Murayama S; Syuto B; Oguma K; Iida H; Kubo S
Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375
[TBL] [Abstract][Full Text] [Related]
10. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
Moriishi K; Syuto B; Kubo S; Oguma K
Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
[TBL] [Abstract][Full Text] [Related]
12. Immuno-crossreactivity between botulinum neurotoxin type C1 or D and exoenzyme C3.
Toratani S; Yokosawa N; Yokosawa H; Ishii S; Oguma K
FEBS Lett; 1989 Jul; 252(1-2):83-7. PubMed ID: 2474453
[TBL] [Abstract][Full Text] [Related]
13. Binding and cytotoxic effects of Clostridium botulinum type A, C1 and E toxins in primary neuron cultures from foetal mouse brains.
Kurokawa Y; Oguma K; Yokosawa N; Syuto B; Fukatsu R; Yamashita I
J Gen Microbiol; 1987 Sep; 133(9):2647-57. PubMed ID: 3329217
[TBL] [Abstract][Full Text] [Related]
14. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
Notermans S; Dufrenne J; Kozaki S
Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody to type F Clostridium botulinum toxin.
Ferreira JL; Hamdy MK; McCay SG; Zapatka FA
Appl Environ Microbiol; 1990 Mar; 56(3):808-11. PubMed ID: 2180373
[TBL] [Abstract][Full Text] [Related]
16. Cloning of a DNA fragment encoding the 5'-terminus of the botulinum type E toxin gene from Clostridium butyricum strain BL6340.
Fujii N; Kimura K; Yashiki T; Indoh T; Murakami T; Tsuzuki K; Yokosawa N; Oguma K
J Gen Microbiol; 1991 Mar; 137(3):519-25. PubMed ID: 2033376
[TBL] [Abstract][Full Text] [Related]
17. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.
Kozaki S; Ogasawara J; Shimote Y; Kamata Y; Sakaguchi G
Infect Immun; 1987 Dec; 55(12):3051-6. PubMed ID: 2824382
[TBL] [Abstract][Full Text] [Related]
18. Cloning of a Clostridium botulinum type B toxin gene fragment encoding the N-terminus of the heavy chain.
Jung HH; Rhee SD; Yang KH
FEMS Microbiol Lett; 1992 Feb; 70(1):69-72. PubMed ID: 1577256
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against tetanus toxin and toxoid.
Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
[TBL] [Abstract][Full Text] [Related]
20. Cloning of the structural gene for Clostridium botulinum type C1 toxin and whole nucleotide sequence of its light chain component.
Kimura K; Fujii N; Tsuzuki K; Murakami T; Indoh T; Yokosawa N; Oguma K
Appl Environ Microbiol; 1991 Apr; 57(4):1168-72. PubMed ID: 2059039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
